We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

OPRK1 rs7817710: Understanding Kappa-Opioid Receptor Variations

rs7817710
Pharmacogenomics
Moderate evidenceGene: OPRK1

The rs7817710 variant is a single-nucleotide polymorphism located within the OPRK1 gene, which encodes the kappa-opioid receptor. Research has investigated its potential associations with behavioral variations in heroin-quit attempts and adverse consequences related to alcohol use.

What each genotype means

G/GModerate attention

Typical opioid receptor response

This genotype is associated with a lower frequency of reported lifetime heroin quit attempts compared to those with the T/T genotype. Research also suggests that individuals with this genotype may experience different rates of lapse during opioid treatment compared to T/T homozygotes. Please discuss any concerns regarding substance use or treatment responses with your healthcare provider.

This genotype is common, though its prevalence varies significantly across different ancestral populations.

G/TModerate attention

Intermediate opioid receptor response

Individuals with this genotype show behavioral patterns that fall between the G/G and T/T groups regarding heroin quit attempts. Research indicates that genetic variation in the OPRK1 gene can influence how individuals respond to opioid-related behaviors and treatment. Please consult with a clinician or pharmacist to discuss how your personal history relates to your treatment plan.

This heterozygous genotype is found at varying frequencies globally, depending on the specific ancestral background of the population.

T/TModerate attention

Increased quit attempt frequency

Research indicates that individuals with this genotype report a significantly higher number of lifetime heroin quit attempts compared to G-allele carriers. Additionally, this genotype has been associated with increased adverse consequences from regular alcohol use in some studies. Because these findings are based on statistical associations in specific populations, please discuss your health history and treatment goals with a qualified medical professional.

This genotype is observed in various populations, with frequencies that differ significantly based on self-identified race and ancestry.

What is the rs7817710 Variant?

The rs7817710 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), located within an intron of the OPRK1 gene. Introns are non-coding regions of DNA that sit between the exons, which are the segments that provide instructions for building proteins. While this variant does not directly change the amino acid sequence of the kappa-opioid receptor protein, researchers study such intronic variants because they may influence how the gene is regulated, expressed, or spliced. By analyzing this specific location on chromosome 8, scientists aim to understand if these subtle genetic differences contribute to individual variations in how people respond to stress or substances of abuse.

The Role of the OPRK1 Gene

The OPRK1 gene provides the blueprint for the kappa-opioid receptor (KOR). This receptor is a member of the G protein-coupled receptor family and is found throughout the central nervous system. It acts as a docking site for endogenous opioids, such as dynorphins, as well as various synthetic substances. When these ligands bind to the receptor, they trigger a cascade of signals that inhibit the release of certain neurotransmitters. This system is fundamentally involved in modulating pain perception, stress responses, and the rewarding or aversive effects of drugs. Because of its central role in these pathways, variations in the OPRK1 gene are frequently studied in the context of addiction medicine and behavioral health.

Research Associations and Evidence

Current research into rs7817710 has explored its relationship with various behavioral phenotypes. Some studies have observed that individuals with the T/T genotype reported a higher frequency of self-reported heroin-quit attempts compared to those carrying the G allele. Additionally, some data have suggested that G-allele carriers may experience more adverse consequences from regular alcohol use. It is important to note that these findings are based on statistical associations within specific study cohorts and do not imply a direct causal link. The evidence strength for these associations is considered moderate, as results can be influenced by environmental factors, the duration of substance use, and the specific populations studied. Further research is required to confirm these patterns across more diverse groups.

Population Frequency

The frequency of the rs7817710 variant is known to be variable across different ancestral populations. Because genetic diversity is high, the prevalence of the T and G alleles can differ significantly depending on the geographic and ethnic background of a group. Researchers often account for these differences when conducting genetic association studies to ensure that findings are not skewed by population stratification.

Interpreting Genetic Information

Genetic information regarding variants like rs7817710 is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions. While research identifies statistical trends in large groups, these findings cannot predict an individual's specific behavior or health outcome. If you have concerns about substance use, addiction, or how your personal health history might interact with your genetics, it is essential to consult with a qualified clinician or pharmacist. They can provide personalized guidance, discuss appropriate screening, and help you navigate evidence-based treatment options tailored to your specific needs.

How common is this variant?

The frequency of the rs7817710 variant is variable across different ancestral populations, reflecting the natural genetic diversity found in human groups.

Frequently asked questions

Can this genetic test predict if I will become addicted to opioids?

No. Genetic variants like rs7817710 are associated with statistical trends in research populations, but they cannot predict individual behavior or the development of addiction. Addiction is a complex condition influenced by a wide range of genetic, environmental, and social factors.

What should I do if I have the T/T genotype?

The T/T genotype is simply a biological observation and does not require specific medical action. If you are concerned about your health or substance use, please speak with a healthcare professional who can provide support and evidence-based advice.

Is rs7817710 the only variant in OPRK1 that matters?

No. The OPRK1 gene contains many different variants, and researchers study several of them to understand their collective impact. Genetic associations are often complex and involve multiple sites within a gene or across the entire genome.

Where can I find more information about OPRK1?

You can find reliable information about the OPRK1 gene through resources like the NIH Genetic Testing Registry or the NCBI Gene database. These platforms provide technical summaries and links to peer-reviewed research.

Sources & further reading

Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs7817710?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in OPRK1